Status:
COMPLETED
Extracorporeal Membrane Oxygenation Physical Training
Lead Sponsor:
Australian and New Zealand Intensive Care Research Centre
Collaborating Sponsors:
Toronto General Hospital
Monash University
Conditions:
Critically Ill, Mechanically Ventilated
Extracorporeal Membrane Oxygenation Complication
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for month...
Detailed Description
The use of extracorporeal membrane oxygenation (ECMO) has expanded dramatically in Australia and globally. While life-saving in the short-term, it is typically associated with prolonged immobility and...
Eligibility Criteria
Inclusion
- adults ≥ 18 years of age
- were physically independent prior to the current admission;
- receiving ECMO (veno-arterial or veno-venous) for at least 24 hours;
- clinician in charge of patient care has no objection to randomisation
Exclusion
- have been in ICU \> 5 days prior to the commencement of ECMO;
- have received ECMO for more than 48 hours;
- in the opinion of the treating clinician, is not expected to recover in 90 days (e.g. intracerebral haemorrhage);
- whom death is expected within 24 hours;
- are unable to communicate in English
Key Trial Info
Start Date :
February 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03328767
Start Date
February 19 2018
End Date
May 1 2020
Last Update
May 8 2020
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
2
St Vincent's Hospital
Sydney, New South Wales, Australia, 2010
3
The Prince Charles Hospital
Chermside West, Queensland, Australia, 4032
4
Alfred Hospital
Melbourne, Victoria, Australia, 3004